An official statement has confirmed that the Cabinet Committee on Economic Affairs (CCEA) has approved a scheme for strengthening tertiary care cancer facilities in India at a cost of Rs.4,697 crore.
According to the statement, the National Programme for Prevention and Control of Cancer, Diabetes, CVDs and Stroke (NPCDCS), approved by the CCEA, seeks to enhance the tertiary care cancer facilities available in the country, address spatial imbalances and reduce waiting period for diagnosis and treatment.
Tumor Markers For Cancer Diagnosis and Prognosis
An ideal tumor marker for a cancer should be specific to that cancer and not generate false positive results.
Advertisement
It also intends to provide access to free/affordable facilities for the poor and increase availability of human resources trained for cancer.
The central government will help the state and union territory governments in setting up State Cancer Institutes (SCI) and Tertiary Care Cancer Centres (TCCC).
![Carcinoid Tumors]( "Carcinoid Tumors")
Carcinoid tumors is a benign tumor that results in carcinoid syndrome. Only 8 to 10% of all carcinoid tumors are associated with the carcinoid syndrome.
Besides enhancing the physical (equipment) capacity, the scheme will help strengthen teaching and research facilities for cancer in the states.
The plan will help in increasing radio therapy/medical oncology and other cancer related facilities in underserved areas and bed capacities for in-patient treatment will also increase, said the statement.
As many as 20 SCIs and 50 TCCCs will be established in different parts of the country.
Financial assistance of upto Rs.120 crore and Rs.45 crore would be provided for each SCI and TCCC respectively.
In addition to diagnosis and treatment, the assisted institutions will impart training to doctors, nurses, technicians and also mentor the activities pertaining to prevention, early detection, treatment and rehabilitation being undertaken in various districts.
Source: IANS
Carcinoid Tumors
Carcinoid tumors is a benign tumor that results in carcinoid syndrome. Only 8 to 10% of all carcinoid tumors are associated with the carcinoid syndrome.
Advertisement
Besides enhancing the physical (equipment) capacity, the scheme will help strengthen teaching and research facilities for cancer in the states.
The plan will help in increasing radio therapy/medical oncology and other cancer related facilities in underserved areas and bed capacities for in-patient treatment will also increase, said the statement.
As many as 20 SCIs and 50 TCCCs will be established in different parts of the country.
Financial assistance of upto Rs.120 crore and Rs.45 crore would be provided for each SCI and TCCC respectively.
In addition to diagnosis and treatment, the assisted institutions will impart training to doctors, nurses, technicians and also mentor the activities pertaining to prevention, early detection, treatment and rehabilitation being undertaken in various districts.
Source: IANS
Pheochromocytoma
Pheochromocytoma is a rare tumor of the adrenal glands that secretes the catecholamines, adrenaline and noradrenaline. Symptoms, diagnosis, treatment of adrenal gland tumor are explained in detail.
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Indian Health News
Tobacco and tobacco related products were found to cause 25 types of diseases and about 40 types of cancer.
The National Medical Devices Policy 2023 approved is aimed to create measures to accelerate the orderly growth of the medical device sector.
A new study exploring the associations between Indigenous food consumption, and malnutrition in four vulnerable tribal Communities in Jharkhand, India.
With a population of 1,428.6 million, India has overtaken China as the world's most populous country as per a new report.
Experts blame the increased consumption of alcohol, junk food, high-fat diets, and sugary drinks are driving a spike in alcoholic fatty liver disease in India.